Didanosine works by reducing the growth of HIV. It belongs to a class of medications called nucleoside analogues.    From Wordnik.com.  [DWS Pill Scribe] Reference

In 1947, Kalckar described the reversibility of nucleoside phosphorylase (5).    From Wordnik.com.  [Nobel Lecture The Purine Path To Chemotherapy] Reference

It's a nucleoside reverse transcriptase inhibitor, or an NRTi, in AIDS speak.    From Wordnik.com.  [Charles Karel Bouley: HIV Prevention Drug: Thanks, But No Thanks] Reference

Adenosine triphosphate (ATP) consists of the nucleoside adenosine linked to three phosphate groups.    From Wordnik.com.  [Press Release: The 1997 Nobel Prize in Chemistry] Reference

After all, diaminopurine had mimicked adenine in many reactions and could be converted to a nucleoside and nucleotide by adenine-metabolizing enzymes.    From Wordnik.com.  [Nobel Lecture The Purine Path To Chemotherapy] Reference

In addition, the RBC analyst believes Gilead's Emtriva will continue to dominate the market for NRTIs, or nucleoside reverse transcriptase inhibitors.    From Wordnik.com.  [Gilead Set For Further Upside On Strong HIV Franchise] Reference

This suggested that other enzymes might also recognize such a side chain as a pentose and that nucleoside analogs of this kind might have antimetabolite properties.    From Wordnik.com.  [Nobel Lecture The Purine Path To Chemotherapy] Reference

While this enzyme had been reported to be formed in herpes virus-infected cells, it was unexpected that an acyclic nucleoside of guanine could serve as its substrate.    From Wordnik.com.  [Nobel Lecture The Purine Path To Chemotherapy] Reference

EFdA is a nucleoside reverse transcriptase inhibitor (NRTIs).    From Wordnik.com.  [innovations-report] Reference

EPZICOM should not be used as part of a triple-nucleoside regimen.    From Wordnik.com.  [Gaea Times (by Simple Thoughts) Breaking News and incisive views 24/7] Reference

At least three non-nucleoside reverse transcriptase inhibitor mutations.    From Wordnik.com.  [MedPageToday.com - medical news plus CME for physicians] Reference

RG7128, a cytosine nucleoside analog for chronic HCV infection, is in two.    From Wordnik.com.  [BioSpace.com Featured News and Stories] Reference

Apricitabine (ATC) is an anti-HIV nucleoside reverse transcriptase inhibitor (NRTI).    From Wordnik.com.  [Health News from Medical News Today] Reference

This was the only nucleoside analogue reverse-transcriptase resistance mutation detected.    From Wordnik.com.  [PLoS Medicine: New Articles] Reference

ANA598 is the Company's non-nucleoside HCV polymerase inhibitor currently in Phase II development.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Thiarabine is a next generation nucleoside analogue that Access has licensed from Southern Research.    From Wordnik.com.  [THE MEDICAL NEWS] Reference

Genelabs Technologies today announced that a non-nucleoside compound from its internal Hepatitis C v.    From Wordnik.com.  [THE MEDICAL NEWS] Reference

The Company is developing ANA598, a non-nucleoside polymerase inhibitor for the treatment of hepatitis C.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

RG7128, a nucleoside analog for chronic HCV infection, is in two Phase 2b clinical trials in combination with.    From Wordnik.com.  [Medlogs - Recent stories] Reference

CP-4126 is a new, patented, cytotoxic drug, consisting of an anti-cancer nucleoside analogue coupled to a lipid chain.    From Wordnik.com.  [WebWire | Recent Headlines] Reference

Intelence is a non-nucleoside reverse transcriptase inhibitor, or NNRTI, that blocks the enzyme HIV needs to multiply.    From Wordnik.com.  [WTOP / Business / Biz Stories] Reference

Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers.    From Wordnik.com.  [Business Wire Travel News] Reference

The FDA granted traditional approval for INTELENCE® (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI).    From Wordnik.com.  [THE MEDICAL NEWS] Reference

RDEA806, for the treatment of HIV, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that has successfully completed a Phase.    From Wordnik.com. Reference

The study recommended that ART include a ritonavir-boosted protease inhibitor (PI / r) or non-nucleoside reverse transcriptase inhibitor.    From Wordnik.com.  [PLoS ONE Alerts: New Articles] Reference

PREZISTA/r was used in combination with an optimized background regimen (OBR) of at least two nucleoside reverse transcriptase inhibitors (NRTIs).    From Wordnik.com.  [THE MEDICAL NEWS] Reference

Study subjects received an optimized nucleoside backbone regimen and were randomized to either once - or twice-daily darunavir boosted with ritonavir.    From Wordnik.com.  [MedPageToday.com - medical news plus CME for physicians] Reference

Data Monitoring Committee (DMC) determines RG7128, a first-in-class nucleoside analog polymerase inhibitor continues to have acceptable safety profile.    From Wordnik.com. Reference

Nov. 25/PRNewswire/-- The FDA granted traditional approval for INTELENCE® (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI).    From Wordnik.com. Reference

RDEA806, for the treatment of HIV, is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that has successfully completed a Phase 2a study in HIV patients.    From Wordnik.com.  [BioSpace.com Featured News and Stories]

• Design, conduct and interpret experiments to evaluate stabilizing and destabilizing events/mechanisms for small molecule nucleoside chemistry drug candidates.    From Wordnik.com.  [Naturejobs - All Jobs] Reference

NS3 protease inhibitors nucleoside reverse transcriptase inhibitors nucleotide reverse transcriptase inhibitors protease inhibitors reverse transcriptase inhibitors.    From Wordnik.com. Reference

Chimerix has advanced a second antiviral compound, CMX157, into Phase 1 clinical studies as a potent nucleoside analogue against multi-drug resistant HIV infections.    From Wordnik.com.  [Latest News from SYS-CON MEDIA] Reference

Our two product candidates for the treatment of HIV, RDEA806 and RDEA427, are non-nucleoside reverse transcriptase inhibitors (NNRTIs), which have successfully completed a.    From Wordnik.com.  [Ardea Biosciences to Present at Four Upcoming Investor Conferences - Yahoo! Finance] Reference

Data Monitoring Committee (DMC) determines RG7128, a first-in-class nucleoside analog polymerase inhibitor continues to have acceptable safety profile - An additional ~300.    From Wordnik.com.  [WN.com - Articles related to MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre] Reference